Paracetamol and Tremfya drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Paracetamol (acetaminophen) and Tremfya (guselkumab). Common drug interactions include escherichia urinary tract infection among females and agranulocytosis among males.

The phase IV clinical study analyzes what interactions people have when they take Paracetamol and Tremfya. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Paracetamol?

Paracetamol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 115,650 Paracetamol users. Check the latest studies of Paracetamol.

What is Tremfya?

Tremfya has active ingredients of guselkumab. eHealthMe is studying from 22,557 Tremfya users. Check the latest studies of Tremfya.

On Jul, 11, 2026

14 people who take Paracetamol and Tremfya together, and have interactions are studied.

Paracetamol and Tremfya drug interactions.

What are the common drug interactions of Paracetamol and Tremfya, by gender? *:

female:

Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
Scar
Urticaria (rash of round, red welts on the skin that itch intensely)
Lower respiratory tract infection
Psoriasis (immune-mediated disease that affects the skin)
Hypertension (high blood pressure)

male:

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Neuropathy peripheral (surface nerve damage)
Drug ineffective

What are the common drug interactions of Paracetamol and Tremfya, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Neuropathy peripheral (surface nerve damage)
Urticaria (rash of round, red welts on the skin that itch intensely)

30-39:

Drug ineffective

40-49:

Hypertension (high blood pressure)

50-59:

Escherichia urinary tract infection (urinary tract infection by escherichia coli)
Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
Scar
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)

60+:

Lower respiratory tract infection
Psoriasis (immune-mediated disease that affects the skin)

What are the existing conditions these people have? *

Psoriasis (immune-mediated disease that affects the skin): 14 people, 100.00%
Psychotic Disorder: 2 people, 14.29%
Joint Pain: 2 people, 14.29%
Productive Cough: 1 person, 7.14%
Optic Neuritis (optic nerve inflammation): 1 person, 7.14%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Back Pain: 1 person, 7.14%
Acne (skin problems that cause pimples): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Paracetamol and Tremfya?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously